Physician questionnaire

OTHER2 trials

Sponsors

Bayer, Case Comprehensive Cancer Center

Conditions

Allogeneic and Autologous Stem Cell TransplantLymphomaMyelomaOphthalmology, Macular DegenerationStem Cell Transplant Complications

Unknown Phase

A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

CompletedNCT04067583

BayerOphthalmology, Macular Degeneration

Start: 2019-10-08End: 2020-04-23Updated: 2021-04-08

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

CompletedNCT04194840

Case Comprehensive Cancer CenterAllogeneic and Autologous Stem Cell Transplant, Lymphoma, Myeloma +1

Start: 2021-05-01End: 2025-03-28Updated: 2025-08-05